AVGN Avigen (MM)

Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, will hold its quarterly conference call to discuss year-end results on Wednesday, February 6, 2008, at 1:00 p.m. ET (10:00 a.m. PT). Kenneth Chahine, Chief Executive Officer, and Michael Coffee, Chief Business Officer, can be heard by calling 888-713-4205 (U.S.) or 617-213-4862 (non-U.S. locations) using passcode 16083697. This call is being webcast by Thomson/CCBN and can be accessed at Avigen�s website at www.avigen.com. The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson�s individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (www.streetevents.com), a password-protected event management site. A rebroadcast of the call will be available shortly after the conclusion of the session. The replay may be accessed over the Internet at www.avigen.com or by calling 888-286-8010 (U.S.) or 617-801-6888 (non-U.S. locations) using passcode 57208063. About Avigen Avigen, Inc. is a biopharmaceutical company focused on unique small molecule therapeutics and biologics to treat serious, chronic neurological disorders, including neuropathic pain and neuromuscular spasm and spasticity. For press releases and other corporate information, visit our website at www.avigen.com.